IRIS
CERIELLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.673
EU - Europa 3.531
AS - Asia 917
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 7
AF - Africa 4
OC - Oceania 3
Totale 23.149
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.619
UA - Ucraina 1.588
DE - Germania 654
FI - Finlandia 557
CN - Cina 523
IE - Irlanda 251
SG - Singapore 219
SE - Svezia 174
RU - Federazione Russa 145
TR - Turchia 115
IT - Italia 65
CA - Canada 52
GB - Regno Unito 35
IN - India 19
EU - Europa 14
BE - Belgio 12
IR - Iran 12
NL - Olanda 9
TW - Taiwan 8
CH - Svizzera 7
FR - Francia 7
HK - Hong Kong 7
KR - Corea 7
PT - Portogallo 6
CZ - Repubblica Ceca 3
ES - Italia 3
HU - Ungheria 3
PL - Polonia 3
RO - Romania 3
AT - Austria 2
AU - Australia 2
BR - Brasile 2
CL - Cile 2
EE - Estonia 2
PK - Pakistan 2
BO - Bolivia 1
BS - Bahamas 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
MA - Marocco 1
MM - Myanmar 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TG - Togo 1
Totale 23.149
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.296
Fairfield 2.612
Ann Arbor 2.388
Houston 1.859
Jacksonville 1.185
Ashburn 1.097
Seattle 1.000
Wilmington 927
Cambridge 925
Dearborn 554
Chandler 528
Boardman 296
Beijing 285
Princeton 265
Dublin 251
Singapore 162
San Diego 138
Izmir 115
Ogden 56
Norwalk 49
Munich 42
Ottawa 42
Des Moines 41
Hefei 37
San Mateo 35
Helsinki 31
Nanjing 30
Grafing 27
Kunming 22
New York 22
Udine 21
Nanchang 16
Guangzhou 13
Jinan 13
Andover 11
Leawood 10
Saint Petersburg 9
Wuhan 9
Brussels 8
Chongqing 8
Fuzhou 8
Augusta 7
Toronto 7
Hangzhou 6
Hong Kong 6
Shenyang 6
Washington 6
Zhengzhou 6
Changsha 5
Dallas 5
Hebei 5
Milan 5
Taipei 5
Zurich 5
Bremen 4
Edinburgh 4
Eindhoven 4
Falls Church 4
Vicenza 4
Ardabil 3
Baotou 3
Charlotte 3
Chengdu 3
Coimbra 3
Guarda 3
Henderson 3
Los Angeles 3
Magione 3
Monmouth Junction 3
Moscow 3
Venice 3
Warsaw 3
Bangalore 2
Bastia 2
Bologna 2
Brno 2
Budapest 2
Chicago 2
Frankfurt am Main 2
Huzhou 2
Islamabad 2
Kashan 2
London 2
Mumbai 2
Nanning 2
Redmond 2
Sacramento 2
Santiago 2
Shanghai 2
Sint-Gillis-Waas 2
Tallinn 2
Wenzhou 2
Winnipeg 2
Xian 2
Yuncheng 2
Adelaide 1
Almería 1
Athens 1
Auckland 1
Bogotá 1
Totale 18.627
Salva come PNG Salva come JPEG
Nome #
Possible role of oxidative stress in the pathogenesis of hypertension. 189
Oxidative stress and diabetes-associated complications. 169
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat 153
The oxygen-release capacity of red blood cells in insulin-dependent diabetics after artificial pancreas. 140
High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. 136
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. 134
Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. 131
Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report. 131
The metabolic syndrome--a postprandial disease? 129
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation 127
Acute hyperglycaemia and oxidative stress generation. 127
Increased prothrombin fragment 1 + 2 in type I diabetic patients. 123
Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. 123
Atypical environmental factor in expressing type I (insulin-dependent) diabetes mellitus. 123
Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. 122
Antioxidant therapy in diabetic complications: what is new? 121
Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. 121
Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy? 120
Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. 120
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. 119
Postprandial glucose regulation: new data and new implications. 119
D-lysine and non-enzymatic glycation. 118
How do we define cure of diabetes? 118
Meal-generated oxidative stress in type 2 diabetic patients 117
Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? 117
Glucose metabolism and hyperglycemia. 116
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. 116
Non-enzymatic glycosylation reduces antithrombin III activity 116
Opiate addict as diabetic patient? 116
Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor 115
Does a common mechanism induce diverse complications of diabetes? 114
Guideline for management of postmeal glucose. 114
Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. 113
Impaired glucose metabolism in heroin and methadone users. 113
Total radical-trapping antioxidant parameter in NIDDM patients. 113
Optimized postprandial glucose control is associated with improved cardiac/vascular function - comparison of three insulin regimens in well-controlled type 2 diabetes. 113
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. 113
Consensus algorithm of the American Diabetes Association and the European Association for the Study of Diabetes: some concerns. 113
Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial. 112
Pregnancy as environmental factor precipitating IDDM. 112
Intra-arterial iloprost for limb ischaemia. 112
Increased glycosylated proteins in opiate addicts. 112
Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. 112
Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. 111
C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene. 111
Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. 111
The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance. 111
Aspirin and non-enzymatic glycation. 110
The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. 110
Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. 109
Meal-generated oxidative stress in diabetes. The protective effect of red wine. 109
Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. 109
Mean red blood cell volume, narcotic addiction, and glucose tolerance 109
Effects of S 21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients 109
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. 108
Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. 108
Antioxidant anti-inflammatory treatment in type 2 diabetes. 108
Evaluation of gliclazide ability to attenuate the hyperglycaemic 'memory' induced by high glucose in isolated human endothelial cells. 108
A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization. 108
Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. 108
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. 107
Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. 107
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 107
Evidence for a reduced heparin cofactor II biological activity in diabetes. 106
Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Effects of short- and long-term simvastatin treatment 106
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. 106
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. 106
Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. 105
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. 105
Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. 105
Fibrinogen levels in opiate addicts. 105
Beta-endorphin and islet hormone release in humans: evidence for interference with cAMP. 104
Glycosaminoglycan therapy for long-term diabetic complications? 104
Macromolecular protein complex: a new way to understand the fibrinogen lowering effect of glycosaminoglycans? 104
Glucose "peak" and glucose "spike": Impact on endothelial function and oxidative stress. 104
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. 104
Point: postprandial glucose levels are a clinically important treatment target. 104
Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. 103
Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics. 103
Postprandial hyperglycemia and cardiovascular disease: is the HEART2D study the answer? 102
Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus. 102
Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity. 102
Is oxidative stress the missing link between insulin resistance and atherosclerosis? 101
Hypothesis: the 'metabolic memory', the new challenge of diabetes. 101
Dual effect of beta-endorphin on insulin secretion in man. 100
Influence of labile glucose adducts on glycosylated protein assay by aminophenylboronic acid affinity chromatography: in vivo studies. 100
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. 100
International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. 100
Hypertension and diabetes: an hypothesis on the possible role of hyperglycemia. 100
Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts. 99
Oxidative stress in diabetes. 99
Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans. 99
Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. 99
Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors. 99
PROactive Study:(r)evolution in the therapy of diabetes? 99
Nicardipine does not cause deterioration of glucose homoeostasis in man: a placebo controlled study in elderly hypertensives with and without diabetes mellitus. 99
Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes. 98
Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. 98
Tolrestat in the primary prevention of diabetic neuropathy. 98
Does postprandial blood glucose matter and why? 98
Totale 11.237
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.038 0 0 0 0 0 0 673 775 513 533 133 411
2020/20213.664 63 429 88 534 141 430 289 430 607 125 394 134
2021/20221.932 92 183 69 136 39 105 135 97 18 404 344 310
2022/20231.473 272 52 7 180 122 479 1 90 179 22 38 31
2023/2024324 51 30 9 5 53 47 3 10 83 14 3 16
2024/2025704 46 292 49 81 50 159 27 0 0 0 0 0
Totale 23.192